These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 7705205)

  • 1. [The effects of different coumarin derivatives].
    Gulba D
    Dtsch Med Wochenschr; 1995 Mar; 120(12):423-4. PubMed ID: 7705205
    [No Abstract]   [Full Text] [Related]  

  • 2. The relationship between maintenance dosages of three vitamin K antagonists: acenocoumarol, warfarin and phenprocoumon.
    van Leeuwen Y; Rosendaal FR; van der Meer FJ
    Thromb Res; 2008; 123(2):225-30. PubMed ID: 18407321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of OTC drug noscapine and acenocoumarol and phenprocoumon.
    Lokhorst B; Rolfes L; Jessurun NT
    Br J Clin Pharmacol; 2019 May; 85(5):1041-1043. PubMed ID: 30809820
    [No Abstract]   [Full Text] [Related]  

  • 4. Transient acquired resistance to the coumarin anticoagulants phenprocoumon and acenocoumarol.
    de Wolff FA; ten Cate JW
    Scand J Haematol; 1979 Nov; 23(5):437-41. PubMed ID: 542805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction of the prostaglandin E derivative rioprostil with oral anticoagulant agents.
    Thijssen HH; Hamulyàk K
    Clin Pharmacol Ther; 1989 Jul; 46(1):110-6. PubMed ID: 2501056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of major bleeding during concomitant use of antibiotic drugs and coumarin anticoagulants.
    Penning-van Beest FJ; Koerselman J; Herings RM
    J Thromb Haemost; 2008 Feb; 6(2):284-90. PubMed ID: 18031295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability of INR in patients on stable long-term treatment with phenprocoumon and acenocoumarol and implications for analytical quality requirements.
    van Geest-Daalderop JH; Péquériaux NC; van den Besselaar AM
    Thromb Haemost; 2009 Sep; 102(3):588-92. PubMed ID: 19718481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Extent and quality of anti-coagulation treatment with coumarin derivatives by the Dutch Thrombosis Services].
    van Geest-Daalderop JH; Sturk A; Levi M; Adriaansen HJ
    Ned Tijdschr Geneeskd; 2004 Apr; 148(15):730-5. PubMed ID: 15119208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Warfarin or acenocoumarol: which is better in the management of oral anticoagulants?
    Barcellona D; Vannini ML; Fenu L; Balestrieri C; Marongiu F
    Thromb Haemost; 1998 Dec; 80(6):899-902. PubMed ID: 9869157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenprocoumon therapy during pregnancy: case report and comparison of the teratogenic risk of different coumarin derivatives.
    Gärtner BC; Seifert CB; Michalk DV; Roth B
    Z Geburtshilfe Perinatol; 1993; 197(6):262-5. PubMed ID: 8147045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural forms of phenprocoumon and warfarin that are metabolized at the active site of CYP2C9.
    He M; Korzekwa KR; Jones JP; Rettie AE; Trager WF
    Arch Biochem Biophys; 1999 Dec; 372(1):16-28. PubMed ID: 10562412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of different oral anticoagulants on diphenylhydantoin (DPH) and tolbutamide metabolism.
    Skovsted L; Kristensen M; Hansen M; Siersbaek-Nielsen K
    Acta Med Scand; 1976; 199(6):513-5. PubMed ID: 59517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International Normalized Ratio (INR) increase in patients taking oral anticoagulant therapy (OAT) and using sildenafil (Viagra).
    Fernández MA; Romá E
    Haematologica; 2003 Dec; 88(12):ELT34. PubMed ID: 14688013
    [No Abstract]   [Full Text] [Related]  

  • 14. The risk of overanticoagulation in patients with heart failure on coumarin anticoagulants.
    Visser LE; Bleumink GS; Trienekens PH; Vulto AG; Hofman A; Stricker BH
    Br J Haematol; 2004 Oct; 127(1):85-9. PubMed ID: 15384981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rapid method for the quantification of the enantiomers of Warfarin, Phenprocoumon and Acenocoumarol by two-dimensional-enantioselective liquid chromatography/electrospray tandem mass spectrometry.
    Vecchione G; Casetta B; Tomaiuolo M; Grandone E; Margaglione M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):507-14. PubMed ID: 17293173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of the plasma protein binding of the coumarin anticoagulants phenprocoumon and its metabolites, warfarin and acenocoumarol, by ultrafiltration and high-performance liquid chromatography.
    de Vries JX; Völker U
    J Chromatogr; 1990 Aug; 529(2):479-85. PubMed ID: 2229265
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prolonged diminished effect of coumarin derivatives after use of rifampicin].
    Harmsze AM; Deneer VH; Wiltink EH
    Ned Tijdschr Geneeskd; 2007 Sep; 151(35):1945-9. PubMed ID: 17907547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective binding of coumarin enantiomers to human alpha1-acid glycoprotein genetic variants.
    Hazai E; Visy J; Fitos I; Bikádi Z; Simonyi M
    Bioorg Med Chem; 2006 Mar; 14(6):1959-65. PubMed ID: 16290938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding low INR in clinical practice.
    Hylek EM; Rose AJ
    Thromb Haemost; 2009 Mar; 101(3):417-8. PubMed ID: 19277399
    [No Abstract]   [Full Text] [Related]  

  • 20. Fatal intoxications by acenocoumarol, phenprocoumon and warfarin: method validation in blood using the total error approach.
    Denooz R; Douamba Z; Charlier C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Aug; 877(23):2344-8. PubMed ID: 19144578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.